New ML model shows importance of microbial load, as opposed to the more often used microbial composition, as a metric in ...

Engineered receptors could lead to more precisely targeted, effective cancer therapies with fewer side effects than existing ...

Innovative drug development "the flavor of 2025" says Ali Pashazadeh, who discusses how the new administration will likely ...

Glioblastoma (GBM) is the most common kind of malignant brain tumor in adults. In recent years, the tumor microenvironment ...

GEN webinar, experts from AbbVie and Benchling will share insights into the current tech landscape, AI readiness, and the ...

StitchR makes it possible to deliver larger payloads with current vectors, expanding the list of diseases targetable by gene therapies.

Immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant—erased all ...

Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...

SyVento says bringing the FlexFactory to Poland makes new therapies available to patients in an efficient and high-quality ...

Healx will use its AI-based drug discovery tech to analyze proprietary Sanofi compound data and identify potential rare disease targets.

Researchers at ETH Zurich combined two CRISPR-Cas methods to decipher how mutations in a cell’s genome affect its function.

It might be possible for people in the future to consume BHB-Phe to drive weight loss without restricting carbohydrates in ...